THERAPY WITH CERTOLIZUMAB PEGOL AND OTHER TNF-A INHIBITORS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY

被引:0
|
作者
Pappas, D. A.
Etzel, C. J. [1 ]
Bedenbaugh, A. [2 ]
Tambiah, J. [3 ]
Greenberg, J. D. [4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UCB Pharma, Smyrna, GA USA
[3] UCB, Smyrna, GA USA
[4] NYU, Sch Med, New York, NY USA
关键词
D O I
10.1016/j.jval.2014.03.256
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMS11
引用
收藏
页码:A43 / A43
页数:1
相关论文
共 50 条
  • [31] DISEASE ACTIVITY AND BIOLOGIC USE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS IN THE PAST 10 YEARS: RESULTS FROM THE CORRONA REGISTRY
    Kavanaugh, A.
    Griffith, J.
    Karki, C.
    Etzel, C. J.
    Kremer, J. M.
    Greenberg, J. D.
    Ganguli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 410 - 411
  • [32] EFFECTIVENESS OF ADALIMUMAB COMBINATION THERAPY WITH METHOTREXATE AND NON-METHOTREXATE CSDMARDS: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, D.
    Griffith, J.
    Schlacher, C. A.
    Suboticki, J. L.
    Harrison, R. W.
    Shan, Y.
    Karki, C.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 552 - 553
  • [33] Efficacy and safety of certolizumab pegol in combination with methotrexate (MTX) in patients with active rheumatoid arthritis despite MTX therapy: Results from the RAPID 2 study
    Smolen, J.
    Brzezicki, J.
    Mason, D.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 187 - 188
  • [34] Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial
    Asai, Shuji
    Kojima, Toshihisa
    Ishikawa, Hajime
    Miyake, Nobumasa
    Kodera, Masanari
    Hasegawa, Hisanori
    Sobue, Yasumori
    Kanayama, Yasuhide
    Shimada, Hiromi
    Hirano, Yuji
    Hidaka, Toshihiko
    Fujibayashi, Takayoshi
    Matsumoto, Takuya
    Kobayakawa, Tomonori
    Yasuoka, Hidekata
    Kato, Takefumi
    Hanabayashi, Masahiro
    Kaneko, Yuko
    Tada, Masahiro
    Murata, Koichi
    Misaki, Kenta
    Ando, Masahiko
    Kuwatsuka, Yachiyo
    Suzuki, Mochihito
    Terabe, Kenya
    Imagama, Shiro
    ARTHRITIS RESEARCH & THERAPY, 2025, 27 (01)
  • [35] Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: Evidence from the CORRONA registry
    Furst, D. E.
    Chang, H.
    Greenberg, J. D.
    Ranganath, V. K.
    Reed, G.
    Ozturk, Z. E.
    Kremer, J. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : 560 - 566
  • [36] EFFECT OF CERTOLIZUMAB PEGOL ON WORKPLACE AND HOUSEHOLD PRODUCTIVITY IN UNITED STATES PATIENTS WITH RHEUMATOID ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE: RESULTS FROM THE PREDICT STUDY
    Kavanaugh, A.
    Mease, P. J.
    Strand, V
    Purcaru, O.
    Curtis, J. R.
    VALUE IN HEALTH, 2014, 17 (03) : A53 - A53
  • [37] Association of Rheumatoid Arthritis Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and Meta-analysis
    Pappas, Dimitrios A.
    Oh, Cheongeun
    Plenge, Robert M.
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    INFLAMMATION, 2013, 36 (02) : 279 - 284
  • [38] Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
    Soo-Kyung Cho
    Yoon-Kyoung Sung
    Dam Kim
    Soyoung Won
    Chan-Bum Choi
    Tae-Hwan Kim
    Jae-Bum Jun
    Dae-Hyun Yoo
    Sang-Cheol Bae
    BMC Musculoskeletal Disorders, 17
  • [39] Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    Kim, Dam
    Won, Soyoung
    Choi, Chan-Bum
    Kim, Tae-Hwan
    Jun, Jae-Bum
    Yoo, Dae-Hyun
    Bae, Sang-Cheol
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17 : 1 - 8
  • [40] Association of Rheumatoid Arthritis Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and Meta-analysis
    Dimitrios A. Pappas
    Cheongeun Oh
    Robert M. Plenge
    Joel M. Kremer
    Jeffrey D. Greenberg
    Inflammation, 2013, 36 : 279 - 284